Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 484,550Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Biogen’s R&D chief Ehlers heads for the exit
Biogen’s R&D chief Ehlers heads for the exit

02 Oct 2019

// Phil Taylor PMLIVE

http://www.pmlive.com/pharma_news/biogens_r_and_d_chief_ehlers_heads_for_the_exit_1311677

Phil Taylor PMLIVE
02 Oct 2019

http://www.pmlive.com/pharma_news/biogen_loses_another_pipeline_drug_to_toxicity_concerns_1301871

Phil Taylor PMLIVE
20 Sep 2019
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Biogen, Eisai throw out remaining Alzheimer's BACE hope

14 Sep 2019

// Ben Adams FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/biogen-eisai-throw-out-remaining-alzheimer-s-bace-hope

Ben Adams FIERCE BIOTECH
14 Sep 2019

https://www.prnewswire.com:443/news-releases/new-data-in-2-oral-and-13-poster-presentations-about-eisais-latest-dementia-pipeline-including-ban2401-elenbecestat-and-lemborexant-to-be-presented-at-alzheimers-association-international-conference-300883623.html

PR NEWSWIRE
11 Jul 2019

https://www.prnewswire.com/news-releases/eisai-to-present-latest-research-about-alzheimers-diseasedementia-pipeline-at-the-14th-international-conference-on-alzheimers--parkinsons-diseases-300816842.html

PRNEWSWIRE
23 Mar 2019

https://www.biospectrumasia.com/news/25/13083/eisai-to-present-latest-research-on-alzheimers-disease-dementia-pipeline-.html

BIOSPECTRUMASIA
23 Mar 2019